These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15721270)

  • 41. Supramolecular polymer formation by cyclic dinucleotides and intercalators affects dinucleotide enzymatic processing.
    Nakayama S; Zhou J; Zheng Y; Szmacinski H; Sintim HO
    Future Sci OA; 2016 Mar; 2(1):FSO93. PubMed ID: 28031943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of 3',5'-cyclic diguanylic acid (cdiGMP) using 1-(4-chlorophenyl)-4-ethoxypiperidin-4-yl as a protecting group for 2'-hydroxy functions of ribonucleosides.
    Yan H; Aguilar AL
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(2):189-204. PubMed ID: 17365797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new synthetic approach to cyclic bis(3'-->5')diguanylic acid.
    Kawai R; Nagata R; Hirata A; Hayakawa Y
    Nucleic Acids Res Suppl; 2003; (3):103-4. PubMed ID: 14510401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A STING-based fluorescent polarization assay for monitoring activities of cyclic dinucleotide metabolizing enzymes.
    Karanja CW; Yeboah KS; Ong WWS; Sintim HO
    RSC Chem Biol; 2021 Feb; 2(1):206-214. PubMed ID: 34458783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclic diguanylic acid behaves as a host molecule for planar intercalators.
    Liaw YC; Gao YG; Robinson H; Sheldrick GM; Sliedregt LA; van der Marel GA; van Boom JH; Wang AH
    FEBS Lett; 1990 May; 264(2):223-7. PubMed ID: 2162785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanisms by which dibutyryl cyclic GMP antagonizes the action of cholecystokinin.
    Miller LJ; Reilly WM; Rosenzweig SA; Jamieson JD; Go VL
    Gastroenterology; 1983 Jun; 84(6):1637-9. PubMed ID: 6301928
    [No Abstract]   [Full Text] [Related]  

  • 47. Overview: molecular changes associated with large bowel cancer and their potential as markers and chemotherapeutic agents.
    Allfrey VG
    Cancer; 1977 Nov; 40(5 Suppl):2576-9. PubMed ID: 200343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Meteoric Rise of the Signaling Molecule Cyclic di-GMP.
    Waters CM
    Microbe Wash DC; 2012; 7(8):353-359. PubMed ID: 25505855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [An aspect of the relations between growth substances and the cancer process].
    Agressologie; 1960 Jul; 2():181-95. PubMed ID: 13728739
    [No Abstract]   [Full Text] [Related]  

  • 50. Bacterial c-di-GMP is an immunostimulatory molecule.
    Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F
    J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity.
    An M; Yu C; Xi J; Reyes J; Mao G; Wei WZ; Liu H
    Nanoscale; 2018 May; 10(19):9311-9319. PubMed ID: 29737353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitotic progression following DNA damage enables pattern recognition within micronuclei.
    Harding SM; Benci JL; Irianto J; Discher DE; Minn AJ; Greenberg RA
    Nature; 2017 Aug; 548(7668):466-470. PubMed ID: 28759889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.
    Smith TT; Moffett HF; Stephan SB; Opel CF; Dumigan AG; Jiang X; Pillarisetty VG; Pillai SPS; Wittrup KD; Stephan MT
    J Clin Invest; 2017 Jun; 127(6):2176-2191. PubMed ID: 28436934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.
    Corrales L; Glickman LH; McWhirter SM; Kanne DB; Sivick KE; Katibah GE; Woo SR; Lemmens E; Banda T; Leong JJ; Metchette K; Dubensky TW; Gajewski TF
    Cell Rep; 2015 May; 11(7):1018-30. PubMed ID: 25959818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.
    Fu J; Kanne DB; Leong M; Glickman LH; McWhirter SM; Lemmens E; Mechette K; Leong JJ; Lauer P; Liu W; Sivick KE; Zeng Q; Soares KC; Zheng L; Portnoy DA; Woodward JJ; Pardoll DM; Dubensky TW; Kim Y
    Sci Transl Med; 2015 Apr; 7(283):283ra52. PubMed ID: 25877890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells.
    Tang CH; Zundell JA; Ranatunga S; Lin C; Nefedova Y; Del Valle JR; Hu CC
    Cancer Res; 2016 Apr; 76(8):2137-52. PubMed ID: 26951929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. cGAS-STING, an important signaling pathway in diseases and their therapy.
    Li Q; Wu P; Du Q; Hanif U; Hu H; Li K
    MedComm (2020); 2024 Apr; 5(4):e511. PubMed ID: 38525112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleotides as Bacterial Second Messengers.
    Cancino-Diaz ME; Guerrero-Barajas C; Betanzos-Cabrera G; Cancino-Diaz JC
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting innate immune pathways for cancer immunotherapy.
    Cao LL; Kagan JC
    Immunity; 2023 Oct; 56(10):2206-2217. PubMed ID: 37703879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.